Evidence map›Paper›PMID 33612107›Full record

ArticleJournal of neuroinflammation2021

Anti-NMDAR encephalitis induced in mice by active immunization with a peptide from the amino-terminal domain of the GluN1 subunit.

Yuewen Ding, Zheye Zhou, Jinyu Chen, Yu Peng, Haitao Wang, Wei Qiu, Wei Xie, Jun Zhang, Honghao Wang

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Antibody-Mediated Mechanisms in Autoimmune Neurological Disorders.The European journal of neuroscience · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Autoimmune neuropsychiatric disorders manifesting with psychosis.The Journal of clinical investigation · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Yuewen DingDepartment of Neurology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, Guangdong, 510515, People's Republic of China.
Zheye ZhouSchool of Biomedical Engineering, Liuzhou Traditional Chinese Medicine Hospital, Guangzhou, Guangdong, People's Republic of China.
Jinyu ChenDepartment of Neurology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, Guangdong, 510515, People's Republic of China.
Yu PengDepartment of Neurology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, Guangdong, 510515, People's Republic of China.
Haitao WangSchool of Pharmaceutical Sciences, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
Wei QiuDepartment of Neurology, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, People's Republic of China.
Wei XieSchool of Traditional Chinese Medicine, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, 510515, Guangdong, People's Republic of China. xieweizn@126.com.
Jun ZhangDepartment of Internal Medicine, Division of Nephrology, University of California at Davis, Houston, TX, USA. jmzhang@ucdavis.edu.
Honghao WangDepartment of Neurology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, Guangdong, 510515, People's Republic of China. wang_whh@163.com.ORCID http://orcid.org/0000-0002-1215-6219
Nanfang Hospital · CNSouthern Medical University · CNSun Yat-sen University · CNUniversity of California System · US

Funding

National Natural Science Foundation of China 81673950National Natural Science Foundation of China 81873158National Natural Science Foundation of China 82004189
6 · The paper itself

Abstract

backgroundAnti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a recently discovered autoimmune syndrome associated with psychosis, dyskinesia, and seizures. However, the underlying mechanisms of this disease remain unclear, in part because of a lack of suitable animal models.

methodsThis study describes a novel female C57BL/6 mouse model of anti-NMDAR encephalitis that was induced by active immunization against NMDARs using an amino terminal domain (ATD) peptide from the GluN1 subunit (GluN1

resultsTwelve weeks after immunization, the immunized mice showed significant memory loss. Furthermore, antibodies from the cerebrospinal fluid of immunized mice decreased the surface NMDAR cluster density in hippocampal neurons which was similar to the effect induced by the anti-NMDAR encephalitis patients' antibodies. Immunization also impaired long-term potentiation at Schaffer collateral-CA1 synapses and reduced NMDAR-induced calcium influx.

conclusionWe established a novel anti-NMDAR encephalitis model using active immunization with peptide GluN1

Indexed as

Amino Acid SequenceAnimalsAnti-N-Methyl-D-Aspartate Receptor EncephalitisAutoantibodiesCells, CulturedFemaleHEK293 CellsHumansMiceMice, Inbred C57BLNerve Tissue ProteinsPeptide FragmentsRatsReceptors, N-Methyl-D-AspartateVaccinationAutoantibodiesGprin1 protein, mouseNerve Tissue ProteinsPeptide FragmentsReceptors, N-Methyl-D-AspartateActive immunizationAmino-terminal domainAnti-NMDA receptor encephalitisCerebrospinal fluidGluN1

Identifiers

PMID33612107
PMCPMC7897387
OpenAlexW3116249626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.